Mounjaro
Mounjaro is tirzepatide approved by the FDA for type 2 diabetes. Two telehealth companies here list it, and neither publishes a price before intake.
Fewer than three providers publish a price for this treatment, so this page is kept out of search results until that changes.
| Provider | Price | Plan and terms | Availability | Visit provider |
|---|---|---|---|---|
| Oak LongevityMounjaro® | Not publishedquoted after intake | Weekly injectionMedication billed separately | All 50 statesNo price published | Visit |
| WellorithmMounjaro® | Not publishedquoted after intake | Weekly injectionMedication billed separately | All 50 statesNo price published | Visit |
Reading these prices
Both providers bill the medication separately from the consultation. With no published prices, there is nothing here to compare yet.
What is not in this table
Prices here come from each company’s own public pages on the date shown in the availability column. A clinician sets the dose after an intake questionnaire, and the dose can change what you pay. Shipping, lab work, and follow-up visits are charged separately by some companies. Telehealth Ledger does not prescribe or dispense medication and does not decide whether a treatment suits you.